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Abstract
Dyspnea is the impairing, cardinal symptom patients with asthma repeatedly experience over the course of the disease.
However, its accurate perception is also crucial for timely initiation of treatment. Reduced perception of dyspnea is
associated with negative treatment outcome, but the underlying brain mechanisms of perceived dyspnea in patients with
asthma remain poorly understood. We examined whether increasing disease duration in fourteen patients with mild-to-
moderate asthma is related to structural brain changes in the insular cortex and brainstem periaqueductal grey (PAG). In
addition, the association between structural brain changes and perceived dyspnea were studied. By using magnetic
resonance imaging in combination with voxel-based morphometry, gray matter volumes of the insular cortex and the PAG
were analysed and correlated with asthma duration and perceived affective unpleasantness of resistive load induced
dyspnea. Whereas no associations were observed for the insular cortex, longer duration of asthma was associated with
increased gray matter volume in the PAG. Moreover, increased PAG gray matter volume was related to reduced ratings of
dyspnea unpleasantness. Our results demonstrate that increasing disease duration is associated with increased gray matter
volume in the brainstem PAG in patients with mild-to-moderate asthma. This structural brain change might contribute to
the reduced perception of dyspnea in some patients with asthma and negatively impact the treatment outcome.
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Introduction
Dyspnea, which is a multidimensional respiratory sensation
containing affective (unpleasantness) and sensory (intensity) aspects
[1–4], is the impairing and threatening cardinal symptom millions
of patients with asthma repeatedly experience over the course of
the disease [5,6]. However, accurate perception of dyspnea is also
important for successful self-management and clinical treatment of
asthma because it motivates patients to initiate appropriate health
behavior such as seeking timely medical and self-treatment in
adequate doses [4,7]. It is well documented that the perception of
dyspnea shows considerable variations between patients and is
often not correlated with simultaneous lung function measure-
ments [8,9]. Importantly, reduced perception of initial broncho-
constriction and dyspnea in patients with asthma can lead to
increased morbidity due to delayed or inadequate medication use,
delayed visits to the physician or emergency department and
might even result in near-fatal and fatal attacks which is often not
related to patients’ baseline lung function [10–14].
The blunted perception of dyspnea in some patients with
asthma is still poorly understood and might involve psychological
factors [15,16], habituation processes [17–19], or reduced
chemosensitivity [13] and seems to be linked to disease duration
[15]. Few previous studies using electroencephalography (EEG)
suggested reduced neural processing of dyspneic respiratory signals
to be another potential cause of blunted dyspnea perception
[18,20–23]. Unfortunately, the current knowledge about brain
processes underlying the perception of dyspnea is still considerably
limited [24,25]; particularly neuroimaging studies in patients with
asthma are needed.
By using functional magnetic resonance imaging (fMRI) we
previously demonstrated that patients with mild-to-moderate
asthma reported reduced affective unpleasantness of resistive load
induced dyspnea when compared to healthy controls [26]. This
was mirrored by reduced insular cortex activations which were
correlated with patients’ asthma duration, but increased asthma-
specific activations in the periaqueductal grey (PAG) during
increasing dyspnea levels. The insular cortex is an important
multisensory integration area and involved in the processing of
various unpleasant bodily signals but also of emotions [27–29],
whereas the PAG plays an important role in the up- and down-
regulation of pain sensations but also in fear and defensive
behaviour [30–32]. We interpreted these previous results as neural
habituation to repeated dyspnea experiences over the course of
disease that reduces the perceived affective unpleasantness of
dyspnea in asthma [26]. However, whereas these findings
demonstrated asthma-specific differences in functional responses
of insular cortex and PAG, they did not allow conclusions about
possible structural alterations in these brain areas which might
have also developed over the course of disease and, thus, could
have impacted the perception of dyspnea. This assumption is
supported by previous findings from research on pain demon-
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chronic pain patients which were correlated with disease duration
and pain reports [33–37]. Similar structural brain changes were
hypothesized in patients with asthma, but have not been tested
[38].
Therefore, by using magnetic resonance imaging (MRI) in
combination with voxel-based morphometry (VBM) the present
study examined, whether increasing asthma duration is related to
structural changes in insular cortex and PAG. Based on asthma-
specific functional brain responses observed in our previous study
[26], we expected decreased gray matter volume in the insular
cortex, but increased gray matter volume in the PAG with
increasing disease duration in the same sample of patients with
mild-to-moderate asthma. We further hypothesized the gray
matter volume in these areas to be related to the perception of
dyspnea unpleasantness.
Methods
Ethics Statement
The study was approved by the medical ethics committee
Hamburg and conducted according to the principles expressed in
the Declaration of Helsinki. Written informed consent was
obtained from all participants.
Participants
We examined fourteen patients with mild-to-moderate asthma,
based on criteria of the Global Initiative for Asthma [5] and
fourteen healthy controls being matched for age and gender. All
subjects participated in our previous study on functional brain
responses to induced dyspnea [26], were free of major respiratory
symptoms in the preceding 4 weeks and had to refrain from taking
their asthma medication (except inhaled corticosteroids) for
16 hours prior to the study. Before testing, all participants were
screened by questionnaires and a diagnostic interview to exclude
significant psychological and medical conditions.
Voxel-based morphometry
Image acquisition. High-resolution MR scanning was per-
formed on a 3 Tesla Magnetom-TRIO MR scanner (Siemens
Medical Solutions, Erlangen, Germany) with a standard head coil.
A T1-weighted structural MRI was acquired for each participant by
using a 3D-FLASH sequence (TR 15 ms, TE 4.9 ms, flip angle 15u,
FOV 2566256, 192 slices, voxel size 16161 mm). Due to the short
echo time (4.9 ms), this sequence minimizes susceptibility artifacts
which can be problematic in functional brain stem images using
T2*-weighted sequences with longer echo times.
Image processing and statistical analysis. Data prepro-
cessing and statistical analyses were performed with SPM8 (www.
fil.ion.ucl.ac.uk/spm) using the voxel-based morphometry toolbox
(VBM8; http://dbm.neuro.uni-jena.de/) that is based on high-
resolution structural 3D MR images and allows for applying voxel-
wise statistics in order to detect regional differences in gray matter
volumes [39,40]. All T1-weighted images were corrected for bias-
field inhomogeneities, spatially normalized and segmented into
gray matter, white matter, and cerebrospinal fluid within the same
generative model [41], and spatially smoothed with a Gaussian
kernel of 6 mm full-width-at-half-maximum. The segmentation
procedure was further extended by accounting for partial volume
effects [42], by applying adaptive maximum a posteriori
estimations [43], and by applying hidden Markov random field
model as described by Gaser [44].
To analyze the relationship between duration of asthma and
gray matter changes in insular cortex and PAG, a single regression
analysis based on a general linear model (GLM) as implemented in
SPM8 was used for the patient group which included the
individual disease duration (in years) as regressor. Based on our
previous findings in functional brain responses [26], we examined
first whether disease duration was correlated with decreased gray
matter volume in the insular cortex. Second, we tested whether
disease duration was correlated with increased gray matter volume
in the PAG. Third, by using Spearman’s rank correlations we
examined whether gray matter volumes in areas with significant
relation to disease duration were correlated with the ratings of
perceived unpleasantness of resistive load induced dyspnea from
our previous functional MRI study. These ratings were obtained
immediately after functional scanning on a verbal descriptor list
consisting of fourteen affective adjectives, which were rated on a 4
point-Likert scale and condensed to a summary score [26]. Finally,
we examined the possibility that structural changes in the patient
group were merely results of normal aging-related changes in
brain structure [40] by running a control analysis in the healthy
control group with age as regressor. Specifically, we tested whether
age was correlated with gray matter changes in those areas that
showed a significant relation to disease duration in the patients
with asthma. The threshold for statistical significance was set to
p,0.05, corrected for multiple comparisons. Regions of interest
(ROIs) were spheres of 6 mm radius around the following center
coordinates: 639, 3, 22 (insular cortex) and 0, 221, 26 (PAG).
Coordinates were chosen from our previous functional imaging
study [26].
Results
According to GINA guidelines [5], studied patients had mild-
intermittent (N=4), mild-persistent (N=6), and moderate-persis-
tent (N=4) asthma. The mean duration of asthma was 16.4 (SD:
8.8) years. No differences in baseline characteristics were found
between patients and controls, except lower FEV1 in patients
(Table 1).
In the patients with asthma, no significant associations between
gray matter volume of the insular cortex and disease duration were
observed. However, for the bilateral PAG we found a significant
increase in gray matter volume with increasing disease duration
(MNI coordinates of peak voxels: 3, 221, 29; Z=3.22; p,0.05
and 23, 222, 29; Z=3.15; p,0.05; Figure 1). As demonstrated
in Figure 2, a significant negative correlation (r=20.51, p,0.05)
Table 1. Mean (SD) baseline characteristics of participants.
Patients with asthma Healthy controls
Age (yr) 27.0 (4.2) 26.6 (6.2)
Sex (female/male), No. 7/7 7/7
Weight (kg) 67.1 (13.4) 66.6 (11.5)
Height (cm) 171.7 (10.1) 174.8 (9.1)
Body Mass Index (kg/m
2) 22.6 (2.6) 21.7 (2.2)
Disease duration (yr) 16.4 (8.8) -
FEV1 (L) 3.83 (.74) 4.35 (1.05)
FEV1 (% predicted) 100.7 (8.8) 110.9 (15.7)
{
FVC (L) 4.79 (1.11) 5.27 (1.18)
FVC (L) (% predicted) 106.9 (10.8) 114.4 (10.1)
FEV1=forced expiratory volume in 1s, FVC=forced vital capacity.
{p,0.05 (t-tests) for the comparison between patients with asthma and healthy
controls.
doi:10.1371/journal.pone.0023739.t001
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the PAG was associated with reduced reports of affective
unpleasantness of resistive load induced dyspnea. In the healthy
control group, no associations were observed between gray matter
volume in the PAG and age or dyspnea unpleasantness ratings,
respectively (Figure 3).
Discussion
Using voxel-based morphometry, the present study shows that
longer duration of asthma was associated with increased gray
matter volume in the brainstem PAG in patients with mild-to-
moderate asthma. This finding seems unrelated to changes in
brain structure caused by normal aging [40] because no age-
related PAG gray matter volume changes were observed in a well
matched healthy control group. Moreover, increased gray matter
volume in the PAG in patients with asthma was related to reduced
ratings for the perceived affective unpleasantness of resistive load
induced dyspnea. Thus, the present findings demonstrate that
increasing disease duration is associated with structural brain
changes in patients with asthma which, in turn, are related to
reduced perception of the affective dyspnea unpleasantness. These
alterations in a brain structure with a well documented role in the
antinociception of pain [30,31] and in fear and defence behaviour
[32], are therefore likely to contribute to the blunted perception of
dyspnea at least in subgroups of patients with asthma.
The present results are in line with our previous study in the
same sample of patients that demonstrated asthma-specific
reductions in perceived dyspnea unpleasantness to be mirrored
by increased functional responses of the PAG during increasing
levels of dyspnea [26]. This was paralleled by asthma-specific
reductions in insular cortex activations during increasing dyspnea
which were also correlated with disease duration and were
moderated by increased PAG activity. However, in the present
study we did not observe significant structural changes in the
insular cortex that were related to the duration of asthma.
Therefore, it might be speculated that decreased insular cortex
activations are the result of structural changes in the PAG with
increasing disease duration which lead to increased antinociceptive
PAG activity. Increased PAG activity, in turn, might lead to
increased inhibition of throughput of dyspneic sensory afferences
to the insular cortex and result in reduced insular activations
without structural changes of this area. However, we cannot
exclude the possibility that the limited sample size reduced the test
power to detect more subtle gray matter changes also in the insular
cortex.
Our present findings are converging with earlier studies using
EEG which similarly showed asthma-specific functional alterations
in the brain processing of respiratory sensations. Specifically, these
studies demonstrated attenuated or even absent respiratory-related
evoked potentials to brief inspiratory occlusions in paediatric and
adult asthma patients [20,21,23], which were partly related to
reduced perception of the respiratory stimuli [20]. The present
results suggest that structural brain changes might contribute to
these alterations in functional brain responses. Given earlier
findings that demonstrated blunted perception of dyspnea to be
associated with inadequate or delayed treatment including near-
fatal and fatal attacks [10–14], the present structural, but also the
previously reported functional brain alterations might constitute
an important risk factor in asthma. Particularly, the present
association of increased PAG gray matter volume with decreased
dyspnea unpleasantness ratings might be critical, because the
affective unpleasantness of perceived dyspnea has been suggested
as being specifically relevant for motivating patients with asthma
to timely take effective medication or to seek professional help
[4,7].
However, although we cannot specify the exact mechanisms
underlying the observed structural brain changes in the PAG in
our patient sample, the most plausible mechanism seems to be a
neuroplastic response of this area to repeated dyspnea experiences
over the course of disease. This converges with our present
observation that asthma duration was correlated with increased
PAG gray matter volume, but also with reduced insular cortex
responses during increasing dyspnea in our previous functional
Figure 1. PAG gray matter volume in relation to the duration of asthma in the patient group. A) Statistical parametric map
demonstrating a significant increase of gray matter volume in the brainstem PAG with increasing duration of asthma (shown at p,0.005,
uncorrected). Gray matter changes are superimposed onto the asthma groups’ mean structural T1 weighted MRI image. B) Mean PAG gray matter
volumes of each patient in relation to the individual duration of asthma.
doi:10.1371/journal.pone.0023739.g001
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short inspiratory occlusions were recently demonstrated in healthy
volunteers when occlusions were repeatedly presented over the
course of an EEG experiment [18]. Moreover, animal models
showed that extended repeated exposures to stimuli mimicking
allergic or mechanical asthma symptoms can result in functional
plasticity in respiration related brain areas [45–47]. For example,
Davenport and colleagues demonstrated state changes in neural
activity in several brain areas including the PAG as well as changes
in gene expression profiles following 10 days of chronic
intermittent tracheal occlusions in rats [46,47].
Further support comes from previous studies on chronic pain
demonstrating gray matter changes in patients with various pain
syndromes [33–37]. For example, Rocca and colleagues [35]
reported similar increases in PAG gray matter volume in patients
with repeated experiences of migraine attacks compared to
controls. Most of these studies demonstrated the structural brain
changes in chronic pain patients to be related to longer disease
duration and, thus, longer experience with painful nociceptive
input [33–35]. Moreover, gray matter changes in pain patients
were shown to be correlated with reports of perceived pain [33,37]
which converges with the present observation of a correlation
between PAG gray matter volume and perceived dyspnea
unpleasantness. Interestingly, a previous study in chronic pain
patients demonstrated that interruption of painful nociceptive
input due to successful treatment not only leads to reduced pain
reports, but also to a reversal of gray matter abnormalities [36]. In
this regard, it will be interesting to examine in controlled
longitudinal studies whether successful compared to unsuccessful
or no treatment of dyspnea in patients with asthma or other
chronic respiratory diseases might lead to a similar reversal in gray
matter alterations.
However, morphometric techniques such as VBM do not allow
conclusions about the specific intracranial processes that led to the
neuroplastic responses observed in the present study, but also in
studies on pain or other sensory experiences [48]. In general, gray
matter increases could be due to various mechanisms including
axonal remodeling, growth of new dendritic spines, synapse
turnover, an increase in cell size, neural or glial cell genesis, spine
density or even changes in blood flow or interstitial fluid, which all
Figure 2. PAG gray matter volume in relation to ratings of dyspnea unpleasantness in patients with asthma. A significant negative
correlation (r=20.51, p,0.05) demonstrated that increased mean PAG gray matter volume in patients with asthma was associated with reduced
ratings of perceived affective unpleasantness of resistive load induced dyspnea.
doi:10.1371/journal.pone.0023739.g002
Figure 3. PAG gray matter volume in relation to age in the
control group. Statistical parametric map demonstrating no increase
of gray matter volume in the brainstem PAG with increasing age
(shown at p,0.005, uncorrected). Gray matter changes are superim-
posed onto the control groups’ mean structural T1 weighted MRI
image.
doi:10.1371/journal.pone.0023739.g003
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cortical plasticity [49–53]. Therefore, future studies with different
methodology will be necessary to examine which of these potential
mechanisms contribute to structural brain changes related to
disease duration in patients with asthma.
When interpreting the present results some limitations should be
kept in mind. Based on our previous observations of asthma-
specific functional brain responses in the PAG and insular cortex
in a rather small sample of patients, we limited the regions of
interest to these two areas in the present study. This might have
prevented the detection of further or more subtle gray matter
changes in other brain areas involved in the processing of dyspnea.
Future studies with larger samples are therefore required. Because
we only examined patients with mild-to-moderate asthma, these
studies might profit from including patients with more severe
forms of the disease in order to examine structural brain
alterations in relation to asthma severity. In this regard, it would
be highly informative to include additional outcome measures that
closely mirror the course of the disease such as frequency of
exacerbations, hospitalisations or emergency treatments which
were not available in the present study. Furthermore, effects of
long-term use of asthma medication on the perception of dyspnea
have been suggested [54,55] and we cannot rule out respective
effects on the underlying brain structures including the PAG.
Therefore, future controlled studies should try to examine the
impact of asthma medication on brain structure. Finally, the
present study can not draw definite conclusions whether structural
brain changes precede altered functional brain responses or vice
versa, which clearly necessitates future studies using longitudinal
designs.
In summary, the present findings demonstrate that increasing
disease duration is associated with increased gray matter volume in
the brainstem PAG in patients with mild-to-moderate asthma
which is related to reduced perception of the affective unpleas-
antness of dyspnea. Future studies are required to examine
whether these structural brain alterations are related to blunted
perception of dyspnea, negative course of disease, asthma severity
and/or asthma medication.
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